| Product Code: ETC8269221 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The market for therapeutic vaccines in Mauritius saw significant growth in 2024, with key importing countries being the UK, Denmark, South Africa, Sweden, and Seychelles. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market, potentially leading to competitive challenges. The impressive compound annual growth rate (CAGR) of 61.4% from 2020 to 2024 highlights the increasing demand for therapeutic vaccines in Mauritius. Additionally, the remarkable growth rate of 87.52% from 2023 to 2024 suggests a rapidly expanding market that presents opportunities for both local and international suppliers.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mauritius Therapeutic Vaccines Market Overview |
3.1 Mauritius Country Macro Economic Indicators |
3.2 Mauritius Therapeutic Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Mauritius Therapeutic Vaccines Market - Industry Life Cycle |
3.4 Mauritius Therapeutic Vaccines Market - Porter's Five Forces |
3.5 Mauritius Therapeutic Vaccines Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Mauritius Therapeutic Vaccines Market Revenues & Volume Share, By Therapeutic Vaccines, 2021 & 2031F |
4 Mauritius Therapeutic Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Mauritius Therapeutic Vaccines Market Trends |
6 Mauritius Therapeutic Vaccines Market, By Types |
6.1 Mauritius Therapeutic Vaccines Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Mauritius Therapeutic Vaccines Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Mauritius Therapeutic Vaccines Market Revenues & Volume, By Peptide Therapeutic Vaccine, 2021- 2031F |
6.1.4 Mauritius Therapeutic Vaccines Market Revenues & Volume, By Cell Therapeutic Vaccine, 2021- 2031F |
6.1.5 Mauritius Therapeutic Vaccines Market Revenues & Volume, By Nucleic Acid Therapeutic Vaccine, 2021- 2031F |
6.2 Mauritius Therapeutic Vaccines Market, By Therapeutic Vaccines |
6.2.1 Overview and Analysis |
6.2.2 Mauritius Therapeutic Vaccines Market Revenues & Volume, By Oncotherapy, 2021- 2031F |
6.2.3 Mauritius Therapeutic Vaccines Market Revenues & Volume, By Hepatitis B, 2021- 2031F |
6.2.4 Mauritius Therapeutic Vaccines Market Revenues & Volume, By Tuberculosis, 2021- 2031F |
6.2.5 Mauritius Therapeutic Vaccines Market Revenues & Volume, By Herpes Simplex Virus, 2021- 2031F |
6.2.6 Mauritius Therapeutic Vaccines Market Revenues & Volume, By Others, 2021- 2031F |
7 Mauritius Therapeutic Vaccines Market Import-Export Trade Statistics |
7.1 Mauritius Therapeutic Vaccines Market Export to Major Countries |
7.2 Mauritius Therapeutic Vaccines Market Imports from Major Countries |
8 Mauritius Therapeutic Vaccines Market Key Performance Indicators |
9 Mauritius Therapeutic Vaccines Market - Opportunity Assessment |
9.1 Mauritius Therapeutic Vaccines Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Mauritius Therapeutic Vaccines Market Opportunity Assessment, By Therapeutic Vaccines, 2021 & 2031F |
10 Mauritius Therapeutic Vaccines Market - Competitive Landscape |
10.1 Mauritius Therapeutic Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Mauritius Therapeutic Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |